第一本拙著的謬誤訂正之清單

拙著《Cancer Inhibitors from Chinese Natural Medicines》自2016年底出版第一版已經6年半了。  疫情的兩年中，常常翻閱舊作，發現了一些謬誤需要勘正。

以下是一份訂正清單，誠請曾購此書的朋友予以註明糾正。雖都是一些小地方，但還是有必要的。  

另外告知大家，CRC出版社已經推出這本拙著的平裝本，書價大幅降低至60美元左右，而不是精裝版原價的379美元。  歡迎有興趣者購置作參考書。 

Cancer Inhibitors from Chinese Natural Medicines  (1^st edition) 

K30263        ISBN: 978-1-4987-8764-2  

A List for the Book errors correction

(First priority correction marked with red color) 

Page 77, Right column, 3^rd line from top.  Correct to “….62.47% with low influence on the …..”

Page 89, Left column, 6^th line from top.     Correct “(10)” to “(13)”.

Page 89, Left column, 4^th paragraph, 2^nd line.  Correct “uterine” to “uridine”.

Page 95, Right column, 2^nd paragraph, 4^th line.  Correct “NCI-H460 (colon)” to “NCI-H460 (lung)”.  

Page 95, Right column, 4^th paragraph, 2^nd line.  Correct “in vitro and in vitro” to “in vitro and in vivo”.

Page 124, Left column, 2^nd paragraph, 4^th line.  Correct “α-tert-butane-” to “α-tert-butyl-”.

Page 139, Right column, 3^rd paragraph, 5^th line.  Correct “primate MDA-MB-231” to “primary MDA-MB-231”.

Page 147, Left column, in Biflavonoids paragraph, 8^th, 11^th, 15^th, 20^th lines.  Correct to “amentoflavone (5)”.

Page 158, Left column, 6^th line from bottom.  Correct “could enhance” to “could inhibit”.

Page 165, Left column, in bottom line.  Correct “Catalposide (12)” to “Catalposide (4)”.

Page 171, Left column, 1^st paragraph, 3^rd line.  Correct “flavenochromane-C (15)” to “kuraridin (20)”.

Page 171, Left column, 1^st paragraph, 6^th line.   Correct “… of matrine (23)” to “….. of kuraridine (20)”.

Page 171, Left column, head of 3^rd paragraph.  Correct “Marein” to “Matrine”.

Page 172, Left column, 2^nd line from bottom of Lectin section.  Correct “s-3 and caspase-9” to “caspase-3 and caspase-9”.

Page 207, Left column, 6^th line from bottom.  Correct “EDSHB” to “EDAHB”.

Page 214, Left column, in bottom line.  Correct “celastrol (4)” to “celastrol (3)”.

Page 219, Left column, 2^nd line from top.  Correct “The tumorigenicity of……” to “The tumoricidal activity on …...”.

Page 299, Left column, 3^rd paragraph, 3^rd line.  Correct “2,5-dihydroxy-…….” to “3,5-dihydroxy-………”.

Page 299, Left column, 3rd paragraph, 6^th line.  Correct “2,5-dihydroxy……..” to “5,8-dihydroxy…….”.

Page 325, Left column, 2^nd paragraph, 10^th line from bottom.  Correct “increasing serum lactate dehydrogenase” to “decreasing serum lactate dehydrogenase”.   

Page 325, Left column, 2nd paragraph, 9^th line from bottom.       Correct “decreased plasma antioxidant activity” to “increasing plasma antioxidant activity”.

Page 425, In right column, 5^th line from bottom.  Correct “another polyacetylene ……” to “another secondary aglucone ……..”.   

Page 425, In right column, move the 5 lines from the bottom {Panaxatrol, another secondary aglucone ……. for further phase II trial.⁴⁸} up to link with the end of 2^nd paragraph.

Page 434, Left column, in the bottom line.  Correct “reduced” to “augmented”.

Page 434, Right column, in the 1^st line of top.  Correct “augmented” to “reduced”.

Page 469, Right column, 3^rd paragraph, 1^st line.  Add “anti-” before “inflammatory……”.

Page 483, Left column, last paragraph, 1^st line.  Add “anti-” before “neoplastic ……”.

Page 488, Left column, 3^rd paragraph.  Change paragraph title of “Protein” to “Glycoprotein”.    And Correct “A protein called arabinogalactan………” to “A highly glycosylated protein called arabinogalactan protein …...”. 

Page 503, Right column, 3^rd paragraph, 4^th and 5^th lines.  Correct “Laicochalcone-A (7) and laicochalcone-E (8) …..” to “Licochalcone-A (7) and licochalcone-E (8) …..”.

Page 532, Left column, 2^nd line.  Correct “PQ (4, 3R,9R,10R),” to “PQ (3R,9R,10R),”.

Page 534, Right column, 2^nd paragraph, 3^rd line.  Correct “gosypetin-7-O-…..” to “gossypetin-7-O-……”.

Page 556, Left column, in the bottom line.  Correct “HP-29” to “HT-29”.

Page 556, Right column, 1^st line.  Correct “HrLa” to “HeLa”.    

Page 556, Right column, 2^nd paragraph, 5^th Line.  Correct “hypoglacaemic,” to “hypoglycaemic,”.

Page 604, Left column, 3^rd paragraph.  Remove all “(4),  (3),  (2), (1)” in this paragraph.

Page 678, Right column, 2^nd line from bottom.  Correct “antiinfertility” to “antifertility”.

Page 680, Right column.  Remove “(3)” in 10^th line and remove “(10)” in 11^th line.

Page 686, Left column, 3^rd line from bottom.  Correct “β-carborine” to “α-carboline”.

Page 713, Right column.  Correct “(KLR, 2)” to “(KLR)” in the 3^rd line;  remove “(3)” in the 6^th line and remove “(4)” in the 12^th line;  and Correct “QLR (3)” to “KLR”.